0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dual Orexin Receptor Antagonist Tablets Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-3Q18056
Home | Market Reports
Global Dual Orexin Receptor Antagonist Tablets Market Research Report 2024
BUY CHAPTERS

Global Dual Orexin Receptor Antagonist Tablets Market Research Report 2026

Code: QYRE-Auto-3Q18056
Report
2026-03-11
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dual Orexin Receptor Antagonist Tablets Market Size

The global Dual Orexin Receptor Antagonist Tablets market was valued at US$ 826 million in 2025 and is anticipated to reach US$ 1320 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Dual Orexin Receptor Antagonist Tablets Market

Dual Orexin Receptor Antagonist Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dual Orexin Receptor Antagonist Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dual Orexin Receptor Antagonist(DORA)tablets are a class of medications designed to treat insomnia by targeting specific receptors in the brain known as orexin receptors.DORAs work by blocking both orexin receptor type 1(OX1R)and orexin receptor type 2(OX2R),thereby inhibiting the wake-promoting effects of orexins.
In the current market, dual orexin receptor antagonist tablets have gradually gained attention in the medical field as an innovative treatment option. With the expanding clinical applications, pharmaceutical research and production are steadily advancing through continuous improvement and enhancement. The growing demand for better sleep quality and symptom relief in neurological disorders drives companies to accelerate their research and development, while the products are undergoing ongoing optimization in both technology and clinical validation.
Looking ahead, future trends indicate that this field will continue to build on the principles of precision medicine and personalized treatment, achieving dual improvements in both functionality and safety. As scientific advancements and deeper understanding of disease pathologies unfold, future products are expected to exhibit more precise control over therapeutic effects and duration, with development models evolving towards interdisciplinary integration and intelligent innovation, ultimately providing patients with more efficient and safer treatment options.
Meanwhile, the market is driven by increasing clinical needs, technological innovation, and supportive policies, yet it also faces several challenges. Factors such as the complexity of clinical trials, heightened regulatory requirements, and intense market competition somewhat restrict the widespread adoption of these medications. Only by overcoming current technological bottlenecks, strengthening international collaboration, and optimizing policy environments can the full market potential be unleashed and industry development be further advanced.
This report delivers a comprehensive overview of the global Dual Orexin Receptor Antagonist Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dual Orexin Receptor Antagonist Tablets. The Dual Orexin Receptor Antagonist Tablets market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dual Orexin Receptor Antagonist Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dual Orexin Receptor Antagonist Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dual Orexin Receptor Antagonist Tablets Market Report

Report Metric Details
Report Name Dual Orexin Receptor Antagonist Tablets Market
Accounted market size in 2025 US$ 826 million
Forecasted market size in 2032 US$ 1320 million
CAGR 7.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Suvorexant
  • Lemborexant
  • Daridorexant
by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Eisal, Idorsia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dual Orexin Receptor Antagonist Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dual Orexin Receptor Antagonist Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dual Orexin Receptor Antagonist Tablets Market growing?

Ans: The Dual Orexin Receptor Antagonist Tablets Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Dual Orexin Receptor Antagonist Tablets Market size in 2032?

Ans: The Dual Orexin Receptor Antagonist Tablets Market size in 2032 will be US$ 1320 million.

Who are the main players in the Dual Orexin Receptor Antagonist Tablets Market report?

Ans: The main players in the Dual Orexin Receptor Antagonist Tablets Market are Merck, Eisal, Idorsia

What are the Application segmentation covered in the Dual Orexin Receptor Antagonist Tablets Market report?

Ans: The Applications covered in the Dual Orexin Receptor Antagonist Tablets Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Dual Orexin Receptor Antagonist Tablets Market report?

Ans: The Types covered in the Dual Orexin Receptor Antagonist Tablets Market report are Suvorexant, Lemborexant, Daridorexant

1 Dual Orexin Receptor Antagonist Tablets Market Overview
1.1 Product Definition
1.2 Dual Orexin Receptor Antagonist Tablets by Type
1.2.1 Global Dual Orexin Receptor Antagonist Tablets Market Value by Type: 2025 vs 2032
1.2.2 Suvorexant
1.2.3 Lemborexant
1.2.4 Daridorexant
1.3 Dual Orexin Receptor Antagonist Tablets by Application
1.3.1 Global Dual Orexin Receptor Antagonist Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Dual Orexin Receptor Antagonist Tablets Market Size Estimates and Forecasts
1.4.1 Global Dual Orexin Receptor Antagonist Tablets Revenue 2021–2032
1.4.2 Global Dual Orexin Receptor Antagonist Tablets Sales 2021–2032
1.4.3 Global Dual Orexin Receptor Antagonist Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dual Orexin Receptor Antagonist Tablets Market Competition by Manufacturers
2.1 Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dual Orexin Receptor Antagonist Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dual Orexin Receptor Antagonist Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Date of Entry into the Industry
2.8 Global Dual Orexin Receptor Antagonist Tablets Market Competitive Situation and Trends
2.8.1 Global Dual Orexin Receptor Antagonist Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dual Orexin Receptor Antagonist Tablets Players Market Share by Revenue
2.8.3 Global Dual Orexin Receptor Antagonist Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dual Orexin Receptor Antagonist Tablets Market Scenario by Region
3.1 Global Dual Orexin Receptor Antagonist Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021–2032
3.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021–2026
3.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2027–2032
3.3 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region: 2021–2032
3.3.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region: 2021–2026
3.3.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region: 2027–2032
3.4 North America Dual Orexin Receptor Antagonist Tablets Market Facts & Figures by Country
3.4.1 North America Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021–2032)
3.4.3 North America Dual Orexin Receptor Antagonist Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dual Orexin Receptor Antagonist Tablets Market Facts & Figures by Country
3.5.1 Europe Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2021–2032)
3.5.3 Europe Dual Orexin Receptor Antagonist Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dual Orexin Receptor Antagonist Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Dual Orexin Receptor Antagonist Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Dual Orexin Receptor Antagonist Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dual Orexin Receptor Antagonist Tablets Market Facts & Figures by Country
3.7.1 Latin America Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021–2032)
3.7.3 Latin America Dual Orexin Receptor Antagonist Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021–2032)
4.1.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021–2026)
4.1.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2027–2032)
4.1.3 Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2021–2032)
4.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021–2032)
4.2.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021–2026)
4.2.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2027–2032)
4.2.3 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Dual Orexin Receptor Antagonist Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021–2032)
5.1.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021–2026)
5.1.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2027–2032)
5.1.3 Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2021–2032)
5.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021–2032)
5.2.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021–2026)
5.2.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2027–2032)
5.2.3 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Dual Orexin Receptor Antagonist Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dual Orexin Receptor Antagonist Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Eisal
6.2.1 Eisal Company Information
6.2.2 Eisal Description and Business Overview
6.2.3 Eisal Dual Orexin Receptor Antagonist Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio
6.2.5 Eisal Recent Developments/Updates
6.3 Idorsia
6.3.1 Idorsia Company Information
6.3.2 Idorsia Description and Business Overview
6.3.3 Idorsia Dual Orexin Receptor Antagonist Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio
6.3.5 Idorsia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dual Orexin Receptor Antagonist Tablets Industry Chain Analysis
7.2 Dual Orexin Receptor Antagonist Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dual Orexin Receptor Antagonist Tablets Production Mode & Process Analysis
7.4 Dual Orexin Receptor Antagonist Tablets Sales and Marketing
7.4.1 Dual Orexin Receptor Antagonist Tablets Sales Channels
7.4.2 Dual Orexin Receptor Antagonist Tablets Distributors
7.5 Dual Orexin Receptor Antagonist Tablets Customer Analysis
8 Dual Orexin Receptor Antagonist Tablets Market Dynamics
8.1 Dual Orexin Receptor Antagonist Tablets Industry Trends
8.2 Dual Orexin Receptor Antagonist Tablets Market Drivers
8.3 Dual Orexin Receptor Antagonist Tablets Market Challenges
8.4 Dual Orexin Receptor Antagonist Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dual Orexin Receptor Antagonist Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dual Orexin Receptor Antagonist Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Dual Orexin Receptor Antagonist Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Dual Orexin Receptor Antagonist Tablets Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Dual Orexin Receptor Antagonist Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Dual Orexin Receptor Antagonist Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Dual Orexin Receptor Antagonist Tablets Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Dual Orexin Receptor Antagonist Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Dual Orexin Receptor Antagonist Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dual Orexin Receptor Antagonist Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dual Orexin Receptor Antagonist Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dual Orexin Receptor Antagonist Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (kg), 2021–2026
 Table 18. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (kg), 2027–2032
 Table 20. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Dual Orexin Receptor Antagonist Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2021–2026
 Table 27. North America Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2027–2032
 Table 28. North America Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Dual Orexin Receptor Antagonist Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2021–2026
 Table 32. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2027–2032
 Table 33. Europe Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Dual Orexin Receptor Antagonist Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Dual Orexin Receptor Antagonist Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Dual Orexin Receptor Antagonist Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Dual Orexin Receptor Antagonist Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2021–2026
 Table 42. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2027–2032
 Table 43. Latin America Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Dual Orexin Receptor Antagonist Tablets Sales (kg) by Type (2021–2026)
 Table 51. Global Dual Orexin Receptor Antagonist Tablets Sales (kg) by Type (2027–2032)
 Table 52. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Dual Orexin Receptor Antagonist Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Dual Orexin Receptor Antagonist Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Type (2021–2026)
 Table 59. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Type (2027–2032)
 Table 60. Global Dual Orexin Receptor Antagonist Tablets Sales (kg) by Application (2021–2026)
 Table 61. Global Dual Orexin Receptor Antagonist Tablets Sales (kg) by Application (2027–2032)
 Table 62. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Dual Orexin Receptor Antagonist Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Dual Orexin Receptor Antagonist Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Application (2021–2026)
 Table 69. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Dual Orexin Receptor Antagonist Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. Merck Dual Orexin Receptor Antagonist Tablets Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Eisal Company Information
 Table 76. Eisal Description and Business Overview
 Table 77. Eisal Dual Orexin Receptor Antagonist Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. Eisal Dual Orexin Receptor Antagonist Tablets Product
 Table 79. Eisal Recent Developments/Updates
 Table 80. Idorsia Company Information
 Table 81. Idorsia Description and Business Overview
 Table 82. Idorsia Dual Orexin Receptor Antagonist Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. Idorsia Dual Orexin Receptor Antagonist Tablets Product
 Table 84. Idorsia Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Dual Orexin Receptor Antagonist Tablets Distributors List
 Table 88. Dual Orexin Receptor Antagonist Tablets Customers List
 Table 89. Dual Orexin Receptor Antagonist Tablets Market Trends
 Table 90. Dual Orexin Receptor Antagonist Tablets Market Drivers
 Table 91. Dual Orexin Receptor Antagonist Tablets Market Challenges
 Table 92. Dual Orexin Receptor Antagonist Tablets Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dual Orexin Receptor Antagonist Tablets
 Figure 2. Global Dual Orexin Receptor Antagonist Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dual Orexin Receptor Antagonist Tablets Market Share by Type: 2025 & 2032
 Figure 4. Suvorexant Product Picture
 Figure 5. Lemborexant Product Picture
 Figure 6. Daridorexant Product Picture
 Figure 7. Global Dual Orexin Receptor Antagonist Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Dual Orexin Receptor Antagonist Tablets Market Share by Application: 2025 & 2032
 Figure 9. Hospital and Clinic
 Figure 10. Retail Pharmacies
 Figure 11. Other
 Figure 12. Global Dual Orexin Receptor Antagonist Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Dual Orexin Receptor Antagonist Tablets Market Size (US$ Million), 2021–2032
 Figure 14. Global Dual Orexin Receptor Antagonist Tablets Sales (kg), 2021–2032
 Figure 15. Global Dual Orexin Receptor Antagonist Tablets Average Price (US$/g), 2021–2032
 Figure 16. Dual Orexin Receptor Antagonist Tablets Report Years Considered
 Figure 17. Dual Orexin Receptor Antagonist Tablets Sales Share by Manufacturers in 2025
 Figure 18. Global Dual Orexin Receptor Antagonist Tablets Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Dual Orexin Receptor Antagonist Tablets Players: Market Share by Revenue in Dual Orexin Receptor Antagonist Tablets in 2025
 Figure 20. Dual Orexin Receptor Antagonist Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Dual Orexin Receptor Antagonist Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021–2032)
 Figure 23. North America Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Country (2021–2032)
 Figure 24. United States Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021–2032)
 Figure 27. Europe Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2021–2032)
 Figure 35. China Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Dual Orexin Receptor Antagonist Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Dual Orexin Receptor Antagonist Tablets by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Dual Orexin Receptor Antagonist Tablets by Type (2021–2032)
 Figure 55. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Dual Orexin Receptor Antagonist Tablets by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Dual Orexin Receptor Antagonist Tablets by Application (2021–2032)
 Figure 58. Global Dual Orexin Receptor Antagonist Tablets Price (US$/g) by Application (2021–2032)
 Figure 59. Dual Orexin Receptor Antagonist Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure